Intrinsic Value of S&P & Nasdaq Contact Us

Baxter International Inc. BAX NYSE

NYSE • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
43/100
2/7 Pass
SharesGrow Intrinsic Value
$25.54
+45.2%
Analyst Price Target
$19.75
+12.3%

Stock Statistics — BAX

Baxter International Inc. (BAX) has a market capitalization of $9.08B and trades at $17.59. The 52-week range is 15.73-32.68.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -10.1, Earnings Per Share (EPS) of $-1.75, annual revenue of $11.24B.

The stock has a beta of 0.62, a last dividend of $0.3600, operates in the Healthcare sector.

Trading Data
Current Price$17.59
52-Week Range15.73-32.68
Volume5.55M
Avg Volume (30D)9.71M
Market Cap$9.08B
Beta (1Y)0.62
Last Dividend$0.3600
Company
IPO Date1981-10-27
Employees38,000
CEOAndrew Hider
CountryUS
ExchangeNYSE
CurrencyUSD
ISINUS0718131099
CUSIP071813109
Income (Latest Year)
Revenue$11.24B
Gross Profit$3.38B
EBITDA$766M
Operating Income$-308M
Net Income$-957M
EPS$-1.75
EPS Diluted$-1.75
Shares Outstanding$513M
Balance Sheet (Latest Year)
Total Assets$20.06B
Current Assets$6.87B
Cash & ST Investments$1.97B
Total Liabilities$13.95B
Total Debt$10B
Net Debt$8.04B
Total Equity$6.1B
Debt / Equity1.64
Valuation Ratios
P/E Ratio-10.1
P/S Ratio0.81
P/B Ratio1.49
EV/EBITDA (approx)11.9
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message